RESPONSE BIOMEDICAL CORP·4

Dec 12, 6:05 PM ET

RESPONSE BIOMEDICAL CORP 4

4 · RESPONSE BIOMEDICAL CORP · Filed Dec 12, 2013

Insider Transaction Report

Form 4
Period: 2013-03-14
Transactions
  • Sale

    Common Stock

    2012-11-28$1.05/sh45,500$47,7750 total
  • Award

    Stock Option (Right to Buy)

    2013-03-14+20,00040,000 total
    Exercise: $3.10Exp: 2023-03-14Common Stock (20,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2012-04-02+20,00020,000 total
    Exercise: $2.20Exp: 2022-04-02Common Stock (20,000 underlying)
Footnotes (3)
  • [F1]Exercise prices shown are denominated in Canadian dollars.
  • [F2]100% of the options vest on the one year anniversary of the date of grant.
  • [F3]On June 19, 2012, the final voting results of the annual meeting of the Company's shareholders effected a consolidation of the Company's outstanding common shares such that each twenty outstanding common shares will be consolidated into one common share.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    PRIMARY DOCUMENT